Healthcare roundup—FDA approves first flu treatment in two decades; Tesla boasts new employee health clinics

FDA approves first flu treatment in nearly 20 years

The Food and Drug Administration approved the first new antiviral flu treatment with a novel mechanism of action in nearly 20 years, it was announced Wednesday. 

The drug Xofluza was approved for patients 12 and older who have had symptoms for no more than 48 hours. 

“With thousands of people getting the flu every year, and many people becoming seriously ill, having safe and effective treatment alternatives is critical. This novel drug provides an important, additional treatment option,” said FDA Commissioner Scott Gottlieb, M.D., in a statement. 

The Centers for Disease Control and Prevention still recommends patients get vaccinated against seasonal flu. (Release

Palo Alto-based Tesla touts new employee health clinics

Tesla has joined the crop of technology companies that have begun offering onsite medical clinics for employees. 

CNBC reports CEO Elon Musk discussed the new clinic during Wednesday's earnings call but did not provide the name for the medical center. Other companies have worked with third-party vendors such as Crossover Health or One Medical to provide similar services. (CNBC)

Toledo-based ProMedica passes on Summa Health

Toledo's ProMedicad was considering the acquisition of three-hospital health system Summa Health—but ultimately decided to pass on the deal, officials said. 

Just a few months ago, ProMedica acquired the HCR ManorCare for $3.3 billion and officials said the deal with Summa would not be prudent. (Toledo Blade)

ACA repeal would impact 102M people with pre-existing conditions